The quality by design enabled the development of cost-effective, simple, precise, and rapid RP-HPLC techniques for determining Pyridoxine (PRD) and Doxylamine (DXA) in the tablet dosage form. Systematic method optimization was performed through central composite design by altering the flow rate and composition of the organic phase in the mobile phase as the critical method parameters for evaluating the necessary analytical attributes, namely the tailing factor, theoretical plate count, and resolution. The optimal separation was achieved on a column with C18 in nature and dimensions of (250 mm length × 4.6 mm id × 5 μm particle size) composed of a blend of acetate buffer and acetonitrile in a volumetric composition of 35:65, at a flow rate of 1.0 ml/minute. Detection was carried out at 254 nm. The PRD and DXA have retention times of 3.053 and 4.357 minutes, respectively. The developed method was useful for the determination of bulk drugs and formulations.
Challa GN, Kunda DR, Hussain Mustaq SJ, Marni N, Ketha S, Gorle U, Jakkula S, Babu Koppisetty BR. QbD assisted RP-HPLC method for determination of Pyridoxine and Doxylamine in pharmaceutical formulation using central composite design. J Appl Pharm Sci. 2024. Online First. http://doi.org/10.7324/JAPS.2025.205442
1. Nuangchamnong N, Niebyl J. Doxylamine succinate-pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: an overview. Int J Women's Health. 2014 Apr 12;6:401-9. 2 Cada DJ, Demaris K, Levien TL, Baker DE. Doxylamine succinate/pyridoxine hydrochloride. Hospital Pharm. 2013 Sep;48(9):762-6. https://doi.org/10.1310/hpj4809-762 | |
3. National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 11224, Doxylamine Succinate; [cited 2024 Aug. 2]. | |
4. Aufiero E, Stitik TP, Foye PM, Chen B. Pyridoxine hydrochloride treatment of carpal tunnel syndrome: a review. Nutr Rev. 2004 Mar 1;62(3):96-104. https://doi.org/10.1301/nr.2004.mar.96-104 | |
5. Adams PW, Wynn V, Rose DP, Seed M, Folkard J, Strong R. Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception. Lancet. 1973 Apr 28;301(7809):897-904. https://doi.org/10.1016/S0140-6736(73)91359-7 | |
6. National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 1054, Pyridoxine; [cited 2024 Aug. 2]. | |
7. Abd El-Hadi HR, Eltanany BM, Zaazaa HE, Eissa MS. HPLC-DAD approach for determination of pyridoxine HCl and doxylamine succinate in pure and pharmaceutical dosage forms: a green stability-indicating assay method. Microchem J 2022 Jan 1;172:106982. https://doi.org/10.1016/j.microc.2021.106982 | |
8. Ribeiro RL, Bottoli CB, Collins KE, Collins CH. Reevaluation of ethanol as organic modifier for use in HPLS-RP mobile phases. J Brazil Chem Soc. 2004;15:300-6. https://doi.org/10.1590/S0103-50532004000200022 | |
9. Giriraj P, Sivakkumar T. Development and validation of a rapid chemometrics assisted RP-HPLC with PDA detection method for the simultaneous estimation of Pyridoxine HCl and Doxylamine succinate in bulk and pharmaceutical dosage form. Chromatogr Res Int. 2014;2014(1):827895. https://doi.org/10.1155/2014/827895 | |
10. Krishna VS, Veni KS, Vijay K, Murali B, Krishna KB, Babu, HS. Development and validation of liquid chromatographic method for the simultaneous estimation of doxylamine succinate, pyridoxine hydrochloride and folic acid in the combined dosage form. World J Pharm Pharm Sci. 2014;April 3(3):78-85. | |
11. Argekar AP, Sawant JG. Simultaneous determination of pyridoxine hydrochloride and doxylamine succinate from tablets by ion pair reversed-phase high-performance liquid chromatography (RP-HPLC). Drug Dev Indus Pharm. 1999 Jan 1;25(8):945-50. https://doi.org/10.1081/DDC-100102255 | |
12. Harde MT, Lakade SH. A stability-indicating HPLC method for estimation of doxylamine succinate in tablets and characterization of its major alkaline stress degradation product. Fut J Pharm Sci. 2021 Dec;7:1-3. https://doi.org/10.1186/s43094-021-00276-6 | |
13. Roy D, Chandra P, Ghosh M, Mondal A, Dagur P, Patel MA, et al. A Stability indicating assay method for the simultaneous estimation of Doxylamine succinate and Pyridoxine hydrochloride in bulk and combined dosage form. Res J Pharm Technol. 2023;16(10):4559-67. https://doi.org/10.52711/0974-360X.2023.00743 | |
14. Koppisetty BR, Prasad YR, Amgoth KM, Yarraguntla SR, Dad? V, Tatapud? HK. Utility of quality by design approach in rp-hplc method development for quantification of lamivudine and effavirenz in combination formulation. J Facult Pharm Ankara Univ. 2023 May 1;47(2):625-36. https://doi.org/10.33483/jfpau.1181816 | |
15. Koppisetty BR, Tatapudi HK, Dadi V, Gayathri PR, Komali P, Challa GN, et al. QbD based RP-HPLC method for simultaneous determination of a emtricitabine, tenofovir diproxil fumarate and efavirenz in tablet dosage form-an application to stability indicating assay. Anal Chem Lett. 2023 May 4;13(3):267-88. https://doi.org/10.1080/22297928.2023.2243279 | |
16. Koppisetty BR, Kollabathula VR, Challa GN, Yarraguntla SR. Quality by design-assisted RP-HPLC method for determination of Ritonavir and Darunavir in pharmaceutical formulation using central composite design. Sep Sci Plus. 2024;7:e202300210. https://doi.org/10.1002/sscp.202300210 | |
17. Dadi V, Medapati S, Baratam JK, Tatapudi HK, Challa GN, Yarguntla SR, et al. Quality by design assisted rp-hplc method for estimation of teriflunomide and its process impurities in drug substance. J Fac Pharm Ankara. 2024;48(3):18. https://doi.org/10.33483/jfpau.1464923 | |
18. Koppisetty BR, Yejella RP, Pawar AK, Yarraguntla SR, Kollabathula VR, Dadi V, et al. Development of a validated RP-HPLC assay method for quantitative separation of Teriflunomide and its process-related impurities in bulk drugs. J Appl Pharm Sci. 2023 Sep 20;13(1):028-33. https://doi.org/10.7324/JAPS.2023.129159 | |
19. Koppisetty BR, Yejella RP, Pawar A, Yarraguntla SR, Dadi V, Naidua CG. A Sensitive azeotropic solvent screening head space gas chromatographic method for teriflunomide drug substance. Curr Trends Drug Disc Dev Deliv. 2023 Dec 15;358:258. https://doi.org/10.1039/9781837671090-00258 | |
20. Guideline IH. Validation of analytical procedures Q2 (R1). Geneva, Switzerland: ICH; 2022. | |
21. Vasudha D, Naidu CG, Koppisetty BR, Yarraguntla SR, Gullapudi TR. A quality by design assisted RP-HPLC method utilizing central composite design for the assay of eliglustat and its organic impurities in drug. Anal Chem Lett. 2024 Sep 28;14:1-15. https://doi.org/10.1080/22297928.2024.2399185 | |
Year
Month